Torthaí cuardaigh - Dave Singh
- 1 - 20 toradh as 177 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
New combination bronchodilators for chronic obstructive pulmonary disease: current evidence and future perspectives de réir Dave Singh
Foilsithe / Cruthaithe 2014Revisão -
2
Small Airway Disease in Patients with Chronic Obstructive Pulmonary Disease de réir Dave Singh
Foilsithe / Cruthaithe 2017Revisão -
3
Pharmacological treatment of stable chronic obstructive pulmonary disease de réir Dave Singh
Foilsithe / Cruthaithe 2021Revisão -
4
Increased ACE2 Expression in Bronchial Epithelium of COPD Patients who are Overweight de réir Andrew Higham, Dave Singh
Foilsithe / Cruthaithe 2020Artigo -
5
The Changing Asthma Management Landscape and Need for Appropriate SABA Prescription de réir Christian Domingo, Dave Singh
Foilsithe / Cruthaithe 2023Artigo -
6
Exhaled breath condensate biomarkers in COPD de réir Zöe Borrill, Kay Roy, Dave Singh
Foilsithe / Cruthaithe 2008Revisão -
7
CRTH2 antagonists in asthma: current perspectives de réir Dave Singh, Arjun Ravi, Thomas Southworth
Foilsithe / Cruthaithe 2017Revisão -
8
Glucocorticoid sensitivity of lipopolysaccharide-stimulated chronic obstructive pulmonary disease alveolar macrophages de réir Jane Armstrong, Carol A. Sargent, Dave Singh
Foilsithe / Cruthaithe 2009Artigo -
9
Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective de réir David Halpin, Dave Singh, Ruth M. Hadfield
Foilsithe / Cruthaithe 2020Revisão -
10
Chronic obstructive pulmonary disease and COVID-19: interrelationships de réir Dave Singh, Alexander G. Mathioudakis, Andrew Higham
Foilsithe / Cruthaithe 2021Revisão -
11
Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial de réir Kai Michael Beeh, Dave Singh, Di Scala, Drollmann
Foilsithe / Cruthaithe 2012Artigo -
12
How inhaled corticosteroids target inflammation in COPD de réir Simon Lea, Andrew Higham, Augusta Beech, Dave Singh
Foilsithe / Cruthaithe 2023Revisão -
13
Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study de réir Dave Singh, Lisa Edwards, Ruth Tal‐Singer, Stephen Rennard
Foilsithe / Cruthaithe 2010Artigo -
14
Pharmacological strategies to reduce exacerbation risk in COPD: a narrative review de réir Marc Miravitlles, Anthony D’Urzo, Dave Singh, Vladimir Koblížek
Foilsithe / Cruthaithe 2016Revisão -
15
COVID-19 and COPD: a narrative review of the basic science and clinical outcomes de réir Andrew Higham, Alexander G. Mathioudakis, Jørgen Vestbo, Dave Singh
Foilsithe / Cruthaithe 2020Revisão -
16
Increased phosphorylated p38 mitogen-activated protein kinase in COPD lungs de réir Kate Gaffey, Sophie Reynolds, Jonathan Plumb, Manminder Kaur, Dave Singh
Foilsithe / Cruthaithe 2012Artigo -
17
-
18
The reproducibility of COPD blood eosinophil counts de réir Thomas Southworth, Gussie Beech, Philip Foden, Umme Kolsum, Dave Singh
Foilsithe / Cruthaithe 2018Carta -
19
The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD de réir Dave Singh, Katharine Abbott-Banner, Thomas Bengtsson, Ken B. Newman
Foilsithe / Cruthaithe 2018Artigo -
20
Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation de réir Robert A. Stockley, David Halpin, Bartolomé R. Celli, Dave Singh
Foilsithe / Cruthaithe 2018Revisão
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Medicine
Internal medicine
COPD
Asthma
Immunology
Pathology
Lung
Biology
Intensive care medicine
Alternative medicine
Pulmonary disease
Anesthesia
Placebo
Disease
Exacerbation
Randomized controlled trial
Biochemistry
Sputum
Tuberculosis
Bronchodilator
Inflammation
Eosinophil
Clinical trial
Gastroenterology
Chemistry
Corticosteroid
Lung function
Obstructive lung disease
Physical therapy
Spirometry